We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
-2.15%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$322M
AUM Growth
-$133M
Cap. Flow
-$85.3M
Cap. Flow %
-26.5%
Top 10 Hldgs %
11.34%
Holding
325
New
83
Increased
75
Reduced
45
Closed
120

Top Buys

Rank Stock Value
1
MGNI icon
Magnite
MGNI
+$3.56M
2
ATRC icon
AtriCure
ATRC
+$3.08M
3
AMRC icon
Ameresco
AMRC
+$3.05M
4
TDOC icon
Teladoc Health
TDOC
+$2.97M
5
SPT icon
Sprout Social
SPT
+$2.86M

Sector Composition

Rank Sector Weight
1 Healthcare 39.85%
2 Technology 22.09%
3 Industrials 12.85%
4 Financials 4.49%
5 Consumer Discretionary 4.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXSM icon
1
Axsome Therapeutics
AXSM
$12.4B
$4.43M 1.37%
75,235
+3,679
+5% +$300K
PLUG icon
2
Plug Power
PLUG
$2.92B
$4.03M 1.25%
1,137,262
+141,525
+14% +$576K
TDOC icon
3
Teladoc Health
TDOC
$1.58B
$3.96M 1.23%
+25,568
New +$2.97M
CCXI
4
DELISTED
ChemoCentryx, Inc.
CCXI
$3.84M 1.19%
95,531
-14,608
-13% -$620K
ICAD
5
DELISTED
iCAD Inc
ICAD
$3.75M 1.16%
510,665
+159,785
+46% +$1.56M
PRNB
6
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$3.67M 1.14%
61,831
+3,584
+6% +$209K
KPTI icon
7
Karyopharm Therapeutics
KPTI
$168M
$3.44M 1.07%
11,923
+145
+1% +$40K
EVER icon
8
EverQuote
EVER
$886M
$3.33M 1.03%
126,742
+6,092
+5% +$215K
RDVT icon
9
Red Violet
RDVT
$859M
$3.09M 0.96%
171,499
+29,622
+21% +$608K
KRYS icon
10
Krystal Biotech
KRYS
$9.88B
$3M 0.93%
69,430
+3,967
+6% +$207K
KRTX
11
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$2.92M 0.91%
40,516
+2,069
+5% +$177K
INSP icon
12
Inspire Medical Systems
INSP
$1.42B
$2.9M 0.9%
48,173
+18,591
+63% +$1.38M
ATRC icon
13
AtriCure
ATRC
$1.77B
$2.88M 0.89%
+85,716
New +$3.08M
CWST icon
14
Casella Waste Systems
CWST
$5.69B
$2.83M 0.88%
72,335
+13,451
+23% +$652K
OESX icon
15
Orion Energy Systems
OESX
$41.1M
$2.79M 0.87%
75,406
+48,474
+180% +$2.12M
GNRC icon
16
Generac Holdings
GNRC
$11.9B
$2.73M 0.85%
29,309
+7,503
+34% +$773K
EIDX
17
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$2.72M 0.85%
55,532
+6,859
+14% +$349K
PLMR icon
18
Palomar
PLMR
$3.65B
$2.71M 0.84%
46,633
-21,237
-31% -$1.11M
ACMR icon
19
ACM Research
ACMR
$5.83B
$2.7M 0.84%
273,948
+110,016
+67% +$1.19M
CSTL icon
20
Castle Biosciences
CSTL
$749M
$2.69M 0.83%
90,163
+24,751
+38% +$747K
AMED
21
DELISTED
Amedisys
AMED
$2.68M 0.83%
14,581
-79
-0.5% -$14.1K
LUNA
22
DELISTED
Luna Innovations Incorporated
LUNA
$2.67M 0.83%
434,929
+11,987
+3% +$88.7K
AMRC icon
23
Ameresco
AMRC
$1.15B
$2.63M 0.82%
+154,478
New +$3.05M
KRMD icon
24
KORU Medical Systems
KRMD
$176M
$2.61M 0.81%
347,820
+158,211
+83% +$1.06M
ASPU
25
DELISTED
ASPEN GROUP, INC.
ASPU
$2.59M 0.8%
324,319
+188,283
+138% +$1.58M

Similar funds

EAM Investors's Q1 2020 Portfolio in Review

As of Q1 2020, EAM Investors held 325 positions worth $322M, down 29% from $455M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $85.3M in Q1 2020, closing 120 positions and reducing 45 holdings. Its most notable exit was Perficient Inc, an estimated $5.02M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 33% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Investors opened a new position in Magnite worth $2.15M.

  • EAM Investors's largest Q1 2020 buy was Magnite: 387,046 shares worth $2.15M.
  • EAM Investors added most to Orion Energy Systems in Q1 2020, an estimated $2.12M increase.
  • EAM Investors's biggest Q1 2020 reduction was Dicerna Pharmaceuticals, Inc., cutting an estimated $1.99M.
  • EAM Investors fully exited Perficient Inc in Q1 2020, selling an estimated $5.02M.
  • EAM Investors's ten largest holdings make up 11% of its $322M portfolio in Q1 2020.
  • EAM Investors opened 83 new positions and closed 120 in Q1 2020.
  • EAM Investors's portfolio value fell 29% quarter-over-quarter to $322M.

Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.